Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.81M | 18.67M | 17.23M | 17.65M | 16.59M |
| Total Other Revenue | 0.00 | 0.00 | -- | -- | -- |
| Total Revenue | 16.81M | 18.67M | 17.23M | 17.65M | 16.59M |
| Cost of Revenue | 7.39M | 7.35M | 7.39M | 8.07M | 7.35M |
| Gross Profit | 9.42M | 11.32M | 9.85M | 9.58M | 9.25M |
| SG&A Expenses | 6.11M | 6.88M | 6.68M | 7.05M | 6.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.13M | 15.80M | 15.62M | 16.66M | 15.85M |
| Operating Income | 1.68M | 2.87M | 1.61M | 994.70K | 745.10K |
| Income Before Tax | 1.51M | 2.70M | 3.75M | 3.00M | 2.74M |
| Income Tax Expenses | 110.40K | 110.40K | -- | -- | -- |
| Earnings from Continuing Operations | 1.40 | 2.59 | 3.75 | 3.00 | 2.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.40M | 2.59M | 3.75M | 3.00M | 2.74M |
| EBIT | 1.68M | 2.87M | 1.61M | 994.70K | 745.10K |
| EBITDA | 2.78M | 4.00M | 2.60M | 1.90M | 1.57M |
| EPS Basic | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 545.44M | 546.93M | 547.64M | 548.34M | 549.34M |
| Average Diluted Shares Outstanding | 549.35M | 550.21M | 550.17M | 550.09M | 557.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
